Abstract
Patients with schizophrenia and their siblings typically show subtle changes of brain structures, such as a reduction of hippocampal volume. Hippocampal volume is heritable, may explain a variety of cognitive symptoms of schizophrenia and is thus considered an intermediate phenotype for this mental illness. The aim of our analyses was to identify single-nucleotide polymorphisms (SNP) related to hippocampal volume without making prior assumptions about possible candidate genes. In this study, we combined genetics, imaging and neuropsychological data obtained from the Mind Clinical Imaging Consortium study of schizophrenia (n = 328). A total of 743,591 SNPs were tested for association with hippocampal volume in a genome-wide association study. Gene expression profiles of human hippocampal tissue were investigated for gene regions of significantly associated SNPs. None of the genetic markers reached genome-wide significance. However, six highly correlated SNPs (rs4808611, rs35686037, rs12982178, rs10424178, rs10406920, rs8170) on chromosome 19p13.11, located within or in close proximity to the genes NR2F6, USHBP1, and BABAM1, as well as four SNPs in three other genomic regions (chromosome 1, 2 and 10) had p-values between 6.75×10⁻⁶ and 8.3×10⁻⁷. Using existing data of a very recently published GWAS of hippocampal volume and additional data of a multicentre study in a large cohort of adolescents of European ancestry, we found supporting evidence for our results. Furthermore, allelic differences in rs4808611 and rs8170 were highly associated with differential mRNA expression in the cis-acting region. Associations with memory functioning indicate a possible functional importance of the identified risk variants. Our findings provide new insights into the genetic architecture of a brain structure closely linked to schizophrenia.
Introduction: The Search for Intermediate Phenotypes
Schizophrenia is a complex, highly heritable disorder, yet identifying its specific genetic drivers remains a significant challenge. Clinical diagnoses often rely on heterogeneous behavioral symptoms, which can obscure the underlying biological signals. To address this, researchers utilize intermediate phenotypes—measurable biological traits that are more closely linked to genetic variation than the clinical syndrome itself.
Hippocampal volume is a prominent candidate for an intermediate phenotype. It is significantly reduced in both patients and their unaffected siblings, exhibits high heritability (40–70%), and is fundamentally linked to memory and cognitive deficits characteristic of the disorder. This study sought to identify specific Single Nucleotide Polymorphisms (SNPs) influencing hippocampal volume through an unbiased, genome-wide approach.
Methods and Data Integration
The study integrated multiple lines of evidence:
- Discovery GWAS: Analysis of 743,591 SNPs in 328 participants from the Mind Clinical Imaging Consortium (MCIC), controlling for age, sex, diagnosis, and intracranial volume.
- Functional Genomics: mRNA expression was analyzed in 138 human hippocampal tissue samples to determine the biological impact of top SNPs.
- External Validation: Findings were cross-referenced with the ENIGMA (n=7,795) and IMAGEN (n=1,663) datasets.
- Cognitive Modeling: Structural Equation Modeling (SEM) was used to test the relationship between genetic variants, hippocampal volume, and memory performance.
Key Results
The genome-wide analysis identified several regions of interest. While no single SNP surpassed the conservative threshold for genome-wide significance ($5 \times 10^{-8}$), a cluster of highly associated variants emerged on chromosome 19.
The most significant association was observed for rs35686037 ($p = 8.3 \times 10^{-7}$). Each risk allele at this locus was associated with an approximately 5% reduction in hippocampal volume (roughly 391 $mm^3$).
The Chromosome 19 Cluster
The strongest signal centered on a block of six highly correlated SNPs on chromosome 19p13.11. This region encompasses genes such as NR2F6, USHBP1, and BABAM1. NR2F6 is of particular interest due to its role in neural development and its interaction with the HPA axis, which is frequently dysregulated in psychiatric conditions.
Functional analysis further supported these findings: variants rs4808611 and rs8170 were significantly associated with the expression of nearby genes (ABHD8 and MRPL34) in hippocampal tissue.
Discussion and Implications
By focusing on a brain-based phenotype, this study identified risk variants that might be missed in traditional case-control studies. The connection between these genetic variants, reduced hippocampal volume, and subsequent poorer memory performance provides a potential pathway from DNA to clinical symptoms.
While the discovery sample size (n=328) limits the statistical power to reach formal genome-wide significance, the convergence of GWAS signals, in silico replication, and functional expression data underscores the relevance of the 19p13.11 locus. Future research in larger cohorts and functional cell models will be essential to pinpoint the causal variants and their exact roles in neurodevelopment and the pathogenesis of schizophrenia.
Summary updated